Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
Clinical trial NCT02448069 · COMPLETED
Trial details
- NCT number
- NCT02448069
- Sponsor
- The University of Texas Health Science Center, Houston
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-08-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.